541 summarised stories about OpenAI, each linking back to the original source. Browse all topics →
OpenAI Blog 11 months ago 44
OpenAI and Retro Bio used a specialized AI model called GPT-4b micro to design proteins for stem cell therapy and longevity research. The model accelerated protein engineering by reducing the iteration cycles required to identify candidates with desired biological properties. This enables faster development timelines for therapies targeting cellular regeneration and aging-related conditions.
The daily briefing
TLDRocket reads 60+ sources, removes duplicate coverage, and summarises the day in two minutes. Free, no spam, unsubscribe anytime.
TLDRocket
3 August 2026
The story of AI in August 2026 is one of consolidation meeting enforcement. Alibaba's Qwen3.8-Max, a 2.4-trillion-parameter mixture-of-experts model with a million-token context window, arrives as a direct challenge to OpenAI and Anthropic's frontier offerings—priced at $2 per million input tokens, it's positioning itself as the capable-and-cheaper alternative that China's AI push has long promised. But the more consequential development is structural: enterprises are finally getting the plumbing to actually deploy these models. June, backed by Salesforce's Marc Benioff, raised $20 million to automate AI integration into legacy systems, scanning corporate infrastructure and generating deployment workflows without expensive consultant fees. This solves what's become clear as the real bottleneck—not model capability, but implementation friction in messy, heterogeneous corporate environments.
Read the full briefing →